Clinical Trials Browser

Recruiting × EC regimen × Breast × Clear all

NCT05834582 2023-04-28

Neoadjuvant Fluzoparib in Germline BRCA-mutated Three-negative Breast Cancer Breast Cancer

Phase 2 Recruiting

Triple Negative Breast Neoplasms